Curated dataset · n=51 verified deals · Not live market data · Scores are descriptive, not forecasts.

Network graph, deal flow, valuation matrix, and acquirer landscape.

eFertility (STB Zorg)→Vitrolife

Acquisition · Cash · VITR · announced May 2, 2024

View in network
  1. Announced

    May 2, 2024

  2. Closed

    May 22, 2024

Economics

Undisclosed

Cash

Terms not publicly disclosed

Target

eFertility (STB Zorg)

Fertility · Fertility science

HQ Breda, Netherlands · Founded 2015

IVF clinic management software — eWitness (step-by-step tracking/tracing) and eBase (specialized EMR compatible with hospital systems); leading presence in Netherlands, expanding across Europe

  • Cision — Vitrolife press release (May 22, 2024)
  • Vitrolife investor relations
  • Vitrolife press release - eFertility acquisition, 2024

Acquirer

Vitrolife (VITR)

Fertility

HQ Gothenburg, Sweden

Why this buyer

Curated copy from the verified dataset — not an 8-K LLM summary

eWitness tracking and eBase EMR add IVF clinic management software to Vitrolife's Technologies business area — expands European digital IVF presence from Netherlands base

Evidence ladder

Single-sourceValue undisclosed
  1. Secondary (press / IR)

    Cision — Vitrolife press release (May 22, 2024)

Limitations

  • Single-source or weak corroboration — treat valuation and timing as directional.
  • Deal value not disclosed in verified record; multiples and comparables exclude this transaction.

Other verified deals by Vitrolife

Acquirer program history not already listed as a valuation peer or adjacency row.

TargetAcquirerAnnouncedValueSector
IgenomixVitrolifeJul 8, 2021Diagnostics

Patient empowerment context

Patient empowerment baseline (HLTH 2022)

No curated mapping — eFertility (STB Zorg) (Fertility). HLTH/Outcomes4Me 2022 baseline is Breast cancer care continuum (HLTH 2022). No curated mapping for this target in the verified crosswalk.

Research workspace (includes heuristic crosswalk) →

Related verified workspaces

Lacuna is a curated public-source sample, not a census of women's-health M&A. Coverage varies by sector, geography, disclosure availability, and women's-health scope. Undisclosed transaction values are excluded from disclosed-value totals.

Curated verified dataset v9 · updated 2026-09-20 · 1 citations on this deal · Data compiled from public sources for educational visualization. Verify independently before any commercial use.